1. Home
  2. SNTI vs ANY Comparison

SNTI vs ANY Comparison

Compare SNTI & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • ANY
  • Stock Information
  • Founded
  • SNTI 2016
  • ANY N/A
  • Country
  • SNTI United States
  • ANY United States
  • Employees
  • SNTI N/A
  • ANY N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • SNTI Health Care
  • ANY Finance
  • Exchange
  • SNTI Nasdaq
  • ANY Nasdaq
  • Market Cap
  • SNTI 14.1M
  • ANY 14.7M
  • IPO Year
  • SNTI N/A
  • ANY N/A
  • Fundamental
  • Price
  • SNTI $2.19
  • ANY $0.86
  • Analyst Decision
  • SNTI
  • ANY Strong Buy
  • Analyst Count
  • SNTI 0
  • ANY 1
  • Target Price
  • SNTI N/A
  • ANY $3.00
  • AVG Volume (30 Days)
  • SNTI 23.2K
  • ANY 222.5K
  • Earning Date
  • SNTI 11-11-2024
  • ANY 11-11-2024
  • Dividend Yield
  • SNTI N/A
  • ANY N/A
  • EPS Growth
  • SNTI N/A
  • ANY N/A
  • EPS
  • SNTI N/A
  • ANY N/A
  • Revenue
  • SNTI $338,000.00
  • ANY $25,026,000.00
  • Revenue This Year
  • SNTI $254.47
  • ANY N/A
  • Revenue Next Year
  • SNTI $169.66
  • ANY N/A
  • P/E Ratio
  • SNTI N/A
  • ANY N/A
  • Revenue Growth
  • SNTI N/A
  • ANY 121.94
  • 52 Week Low
  • SNTI $1.52
  • ANY $0.57
  • 52 Week High
  • SNTI $8.48
  • ANY $4.09
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 39.08
  • ANY 47.09
  • Support Level
  • SNTI $2.08
  • ANY $0.83
  • Resistance Level
  • SNTI $2.56
  • ANY $0.91
  • Average True Range (ATR)
  • SNTI 0.24
  • ANY 0.06
  • MACD
  • SNTI -0.04
  • ANY -0.00
  • Stochastic Oscillator
  • SNTI 10.57
  • ANY 16.17

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: